BIOGEN INC. Stock Issued During Period, Shares, Conversion of Convertible Securities
BIOGEN INC. (BIIB) reported Stock Issued During Period, Shares, Conversion of Convertible Securities of 493.26 thousand shares for the 1-month period ending 2011-03-31, per its 10-K filed 2012-02-03.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities · last filed 2012-02-03
- 2011-03-31: Stock Issued During Period, Shares, Conversion of Convertible Securities 1 month 493.26K shares.
| Period end | Stock Issued During Period, Shares, Conversion of Convertible Securities 1 month |
|---|---|
| 2011-03-31 | 493.26K shares 10-K · filed 2012-02-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |